{"id":"https://openalex.org/W2126947618","doi":null,"title":"A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.","display_name":"A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.","publication_year":2003,"publication_date":"2003-07-15","ids":{"openalex":"https://openalex.org/W2126947618","mag":"2126947618","pmid":"https://pubmed.ncbi.nlm.nih.gov/12874007"},"language":"en","primary_location":{"id":"pmid:12874007","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12874007","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ahmed M Mansour","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed M Mansour","raw_affiliation_strings":["Tumor Biology Center, Breisacher Strasse 117, 79106 Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tumor Biology Center, Breisacher Strasse 117, 79106 Freiburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037655243","display_name":"Joachim Drevs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joachim Drevs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124645209","display_name":"Norbert Esser","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norbert Esser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110340071","display_name":"Farid M.A. Hamada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farid M Hamada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057966287","display_name":"Osama Ahmed Badary","orcid":"https://orcid.org/0000-0002-5676-6692","observed_orcids":["https://orcid.org/0000-0002-5676-6692"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Osama A Badary","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064684263","display_name":"Clemens Unger","orcid":"https://orcid.org/0000-0003-0461-2488","observed_orcids":["https://orcid.org/0000-0003-0461-2488"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clemens Unger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109512554","display_name":"Iduna Fichtner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iduna Fichtner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004610787","display_name":"Felix Kratz","orcid":"https://orcid.org/0000-0001-9509-1299","observed_orcids":["https://orcid.org/0000-0001-9509-1299"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felix Kratz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.756,"has_fulltext":false,"cited_by_count":197,"citation_normalized_percentile":{"value":0.91030195,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"63","issue":"14","first_page":"4062","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.5884000062942505,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.5884000062942505,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.3596000075340271,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/doxorubicin-prodrug","display_name":"doxorubicin prodrug","score":0.9240000247955322},{"id":"https://openalex.org/keywords/mmp-2","display_name":"MMP-2","score":0.9399999976158142},{"id":"https://openalex.org/keywords/maleimide-derivatives","display_name":"maleimide derivatives","score":0.6679999828338623},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6209999918937683},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8589296340942383},{"id":"https://openalex.org/C109523444","wikidata":"https://www.wikidata.org/wiki/Q424216","display_name":"Matrix metalloproteinase","level":2,"score":0.6685699224472046},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.6268262267112732},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.5963525772094727},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5904250144958496},{"id":"https://openalex.org/C2779564779","wikidata":"https://www.wikidata.org/wiki/Q7706647","display_name":"Tetrapeptide","level":3,"score":0.5899083018302917},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5251833200454712},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5001673698425293},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.4828124940395355},{"id":"https://openalex.org/C2778597219","wikidata":"https://www.wikidata.org/wiki/Q11721976","display_name":"Human serum albumin","level":2,"score":0.46541929244995117},{"id":"https://openalex.org/C165616093","wikidata":"https://www.wikidata.org/wiki/Q424232","display_name":"Serum albumin","level":2,"score":0.4128711223602295},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3832656741142273},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3692966401576996},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2778800427913666},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.20400270819664001},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17795118689537048},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13309654593467712},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000418","descriptor_name":"Albumins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008301","descriptor_name":"Maleimides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020778","descriptor_name":"Matrix Metalloproteinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12874007","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12874007","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2126947618","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12874007","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1517260951","https://openalex.org/W1550628230","https://openalex.org/W1829026717","https://openalex.org/W1978689713","https://openalex.org/W1983609115","https://openalex.org/W2002516695","https://openalex.org/W2051849794","https://openalex.org/W2052626837","https://openalex.org/W2061072777","https://openalex.org/W2066238924","https://openalex.org/W2084480843","https://openalex.org/W2086299681","https://openalex.org/W2101160383","https://openalex.org/W2104692426","https://openalex.org/W2116385570","https://openalex.org/W2126316585","https://openalex.org/W2155765426","https://openalex.org/W2159497037","https://openalex.org/W3192823395"],"related_works":["https://openalex.org/W2159497037","https://openalex.org/W2037326742","https://openalex.org/W2121354326","https://openalex.org/W2147882675","https://openalex.org/W2087409856","https://openalex.org/W2494624088","https://openalex.org/W2587722915","https://openalex.org/W2013644553","https://openalex.org/W2007511662","https://openalex.org/W2046507201"],"abstract_inverted_index":{"The":[0,92],"progression":[1],"of":[2,9,12,26,45,68,89,95,135],"malignant":[3],"melanoma":[4,126],"is":[5,47,129],"characterized":[6,130],"by":[7,102,131],"overexpression":[8],"a":[10,20,36,55,64,72,105,132],"number":[11],"matrix":[13],"metalloproteinases":[14],"(MMPs),":[15],"especially":[16],"MMP-2,":[17],"which":[18,41,128],"play":[19],"critical":[21],"role":[22],"in":[23,40,122],"the":[24,30,42,86,118,123],"degradation":[25],"basement":[27],"membranes":[28],"and":[29,83,99,109],"extracellular":[31],"matrix.":[32],"Consequently,":[33],"we":[34],"assessed":[35],"drug":[37],"targeting":[38],"strategy":[39],"protease":[43],"activity":[44],"MMP-2":[46,73,103],"exploited":[48],"to":[49,85,117],"release":[50],"an":[51],"anticancer":[52],"agent":[53],"from":[54],"macromolecular":[56],"carrier,":[57],"i.e.,":[58],"circulating":[59,90],"albumin.":[60,91],"For":[61],"this":[62],"purpose,":[63],"water-soluble":[65],"maleimide":[66],"derivative":[67],"doxorubicin":[69,106,121],"(1)":[70],"incorporating":[71],"specific":[74],"peptide":[75],"sequence":[76],"(Gly-Pro-Leu-Gly-Ile-Ala-Gly-Gln)":[77],"was":[78,97,115],"developed":[79],"that":[80],"binds":[81],"rapidly":[82],"selectively":[84],"cysteine-34":[87],"position":[88],"albumin-bound":[93],"form":[94],"1":[96,114],"efficiently":[98],"specifically":[100],"cleaved":[101],"liberating":[104],"tetrapeptide":[107],"(Ile-Ala-Gly-Gln-DOXO)":[108],"subsequently":[110],"doxorubicin.":[111],"In":[112],"vivo,":[113],"superior":[116],"parent":[119],"compound":[120],"A375":[124],"human":[125],"xenograft,":[127],"high":[133],"expression":[134],"MMP-2.":[136]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}